| |
|
| Saied Asfa, MD |
OUTSIDE RELATIONSHIPS: Valley Health Plan-Credential committee - Board - Financially Compensated
|
| Devra Becker, MD |
AFFILIATIONS: Board member: ACEPS, ASMS, FACE: section editor of journal; OUTSIDE RELATIONSHIPS: Lazurite, LLC - Other - Not Financially Compensated, Push2Spin - Other - Not Financially Compensated;
|
| Thomas Fiala, MD |
AFFILIATIONS: Section Editor - Aesthetic Surgery Journal; Chair - Finance & Investment Committee, The Aesthetic Society, Chair - Cosmetic Section, In-Service Exam Committee, and member of L3E exam creation committee; OUTSIDE RELATIONSHIPS: Dominion Aesthetics - Researcher - Financially Compensated;
|
| Lawrence Glassman, MD |
AFFILIATIONS: ASPS Chair Life-Long Learning Exercise in Aesthetic Surgery, ASPS In-Service Committee member Cosmetic and Breast (past Chair), past ASPS In-Service Committee overall Chair;
|
| David Kahn, MD |
AFFILIATIONS: The Aesthetic Society committee including the Program Committee, the Leadership development committee, and Vice-Chair of the Continuing medical education committee; OUTSIDE RELATIONSHIPS: The American Medical Foundation for Peer Review and Education - Contractor - Financially Compensated, Medical Review Institute of America - Contractor - Financially Compensated, Dane Street - Contractor - Financially Compensated, Maximus - Contractor - Financially Compensated; PUBLIC: United Healthcare - Ticker: UNH - Type: Stock - Shares (all types) - Amount: $0-$1,000 - Relationship Ended: Yes, Viking Therapeutics - Ticker: VKTX - Type: Stock - Options (all types), Stock - Shares (all types) - Amount: $5,001-$10,000 - Relationship Ended: No, Vertex Pharmaceuticals - Ticker: VRTX - Type: Stock - Shares (all types) - Amount: $1,001-$5,000 - Relationship Ended: No, Eli Lilly - Ticker: LLY - Type: Stock - Shares (all types) - Amount: $0-$1,000 - Relationship Ended: Yes, Novo Nordisk - Ticker: NVO - Type: Stock - Shares (all types) - Amount: $0-$1,000 - Relationship Ended: Yes, PDS Biotechnology - Ticker: PDSB - Type: Stock - Shares (all types) - Amount: $0-$1,000 - Relationship Ended: Yes, Pfizer - Ticker: PFE - Type: Stock - Shares (all types) - Amount: $0-$1,000 - Relationship Ended: Yes, Aquestive Therapeutics - Ticker: AQST - Type: Stock - Shares (all types) - Amount: $0-$1,000 - Relationship Ended: No, Intuitive Surgical - Ticker: ISRG - Type: Stock - Shares (all types) - Amount: $1,001-$5,000 - Relationship Ended: No;
|
| Michele Manahan, MD |
AFFILIATIONS: AAPS, AMA, ASRM, The Aesthetic Society, MedChi, The Maryland State Medical Society, Baltimore City Medical Society, ACS, ACEPS, American Board of Plastic Surgery;
|
| Cindy McCord, MD |
OUTSIDE RELATIONSHIPS: Cigna - Director - Not Financially Compensated, EviCore - Director - Financially Compensated; PUBLIC: Novo Nordisk - Ticker: n/a - Type: No Compensation - Amount: $0-$1,000 - Relationship Ended: No, Pfizer - Ticker: n/a - Type: No Compensation - Amount: $1,001-$5,000 - Relationship Ended: No, Johnson &Johnson - Ticker: n/a - Type: No Compensation - Amount: $0-$1,000 - Relationship Ended: No;
|
| Sachin Shridharani, MD |
AFFILIATIONS: ASPS, ASAPS, ACS, NYSSPS, NYRSPS, ASJ, PRS, NESPS, PSRC; OUTSIDE RELATIONSHIPS: Allergan - Consultant - Financially Compensated, Galderma - Consultant - Financially Compensated, Prollenium - Consultant - Financially Compensated, Raziel - Consultant - Financially Compensated, Apyx Medical - Consultant - Financially Compensated, Revance - Consultant - Financially Compensated; PUBLIC: Allergan - Ticker: AGN - Type: Consulting Fees, Payment for Speaking Engagement - Amount: $500,001-$1,000,000 - Relationship Ended: No, Apyx Medical - Ticker: APYX - Type: Consulting Fees, Payment for Speaking Engagement - Amount: $50,001-$100,000 - Relationship Ended: No;
|
| Cindy Wu, MD |
AFFILIATIONS: Clinical Editor for the Aesthetic Surgery Journal and Aesthetic Surgery Journal Open Forum, In-Service Exam Writing Committee Member, Cosmetic Subcommittee; OUTSIDE RELATIONSHIPS: Allergan - Consultant - Financially Compensated; |